Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders

Valeria VisconteR V Tiu


In humans, the majority of all protein-coding transcripts contain introns that are removed by mRNA splicing carried out by spliceosomes. Mutations in the spliceosome machinery have recently been identified using whole-exome/genome technologies in myelodysplastic syndromes (MDS) and in other hematological disorders. Alterations in splicing factor 3 subunit b1 (SF3b1) were the first spliceosomal mutations described, immediately followed by identification of other splicing factor mutations, including U2 small nuclear RNA auxillary factor 1 (U2AF1) and serine arginine-rich splicing factor 2 (SRSF2). SF3b1/U2AF1/SRSF2 mutations occur at varying frequencies in different disease subtypes, each contributing to differences in survival outcomes. However, the exact functional consequences of these spliceosomal mutations in the pathogenesis of MDS and other hematological malignancies remain largely unknown and subject to intense investigation. For SF3b1, a gain of function mutation may offer the promise of new targeted therapies for diseases that carry this molecular abnormality that can potentially lead to cure. This review aims to provide a comprehensive overview of the emerging role of the spliceosome machinery in the biology of MDS/hem...Continue Reading


Jun 1, 1982·British Journal of Haematology·J M BennettC Sultan
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·F YamaguchiR S Morrison
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·G B SilbersteinC W Daniel
Dec 16, 1997·Trends in Biochemical Sciences·J L Corden, M Patturajan
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·M M HuntsmanE G Jones
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·I D'SouzaG D Schellenberg
Mar 4, 2000·Journal of Psychiatric Research·M P VawterW J Freed
Mar 29, 2005·FEBS Letters·Núria López-BigasRoderic Guigó
Jun 16, 2005·Nature Reviews. Molecular Cell Biology·Arianne J MatlinChristopher W J Smith
Oct 26, 2005·Current Opinion in Chemical Biology·Saba Valadkhan
Aug 18, 2006·Nucleic Acids Research·Nihar ShethRavi Sachidanandam
Feb 24, 2007·Nature Reviews. Molecular Cell Biology·Greg B G MoorheadAnnegret Ulke-Lemée
Aug 22, 2007·Nature Chemical Biology·Brian Rymond
Feb 21, 2008·European Journal of Haematology·Thorvardur R HalfdanarsonWilliam J Hogan
Nov 26, 2008·Journal of Molecular Evolution·Manuela MarzPeter F Stadler
Sep 24, 2009·Nature Reviews. Molecular Cell Biology·Mo Chen, James L Manley
Nov 3, 2009·Journal of Medicinal Chemistry·Chandraiah LagisettiThomas R Webb
Nov 13, 2009·Acta Haematologica·Alex D SheftelPrem Ponka
Nov 18, 2009·The Journal of Pathology·Amanda J Ward, Thomas A Cooper
Aug 21, 2010·Leukemia·Hideki MakishimaJaroslaw P Maciejewski
Nov 3, 2010·Genes & Development·Charles J David, James L Manley
Nov 12, 2010·The New England Journal of Medicine·Timothy J LeyRichard K Wilson
Jan 6, 2011·The FEBS Journal·Gourisankar Ghosh, Joseph A Adams
Apr 19, 2011·Trends in Genetics : TIG·Suzan M Hammond, Matthew J A Wood
Jun 3, 2011·Haematologica·Mario Cazzola, Rosangela Invernizzi
Oct 11, 2011·The FEBS Journal·Akira YokoiYoshiharu Mizui
Oct 15, 2011·The New England Journal of Medicine·Elli PapaemmanuilChronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
Oct 15, 2011·Blood·Luca MalcovatiChronic Myeloid Disorders Working Group of the International Cancer Genome Consortium and of the Associazione Italiana per l
Nov 26, 2011·Experimental and Molecular Pathology·Shiho SuzukiMasanobu Kitagawa
Dec 14, 2011·The New England Journal of Medicine·Lili WangCatherine J Wu
Dec 14, 2011·Nature Genetics·Timothy A GraubertMatthew J Walter
Feb 7, 2012·Blood·Y Saunthararajah, Jaroslaw P Maciejewski


Jul 16, 2013·Cell Death and Differentiation·M Ridinger-SaisonC Guillouf
Jan 15, 2013·Nature Genetics·J William HarbourAnne M Bowcock
Apr 25, 2013·Nature Reviews. Cancer·Megan J BywaterRoss D Hannan
Apr 10, 2013·Blood·Youzhong Wan, Catherine J Wu
May 10, 2013·BMC Medicine·Víctor QuesadaCarlos López-Otín
Aug 16, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Manasi MalikSteven Estus
Nov 20, 2013·Leukemia·R Itzykson, P Fenaux
Dec 17, 2014·Expert Opinion on Drug Metabolism & Toxicology·Anna WojtuszkiewiczJacqueline Cloos
Feb 21, 2016·Pharmacology & Therapeutics·Susumu OhyaKatsuhiko Muraki
Apr 22, 2014·Immunology and Allergy Clinics of North America·Siham BibiMichel Arock
May 15, 2013·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Amer M ZeidanSteven Gore
Dec 17, 2014·Immunological Reviews·Brittany A Woods, Ross L Levine
Oct 2, 2013·Advances in Biological Regulation·J BoultwoodAndrea Pellagatti
Apr 29, 2014·Molecular Immunology·Erinn SouciePatrice Dubreuil
Aug 15, 2015·BioMed Research International·Vânia Gonçalves, Peter Jordan
Nov 6, 2014·Leukemia·G D Te RaaE Eldering
Dec 24, 2013·Blood·Mikkael A Sekeres, Corey Cutler
Jan 30, 2015·International Journal of Hematology·David RodríguezCarlos López-Otín
May 2, 2014·Leukemia·A Kurtovic-KozaricRichard A Padgett
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mikkael A Sekeres
Oct 17, 2017·The Journal of Cell Biology·María Moriel-CarreteroAngelos Constantinou
Nov 6, 2012·Nature Reviews. Drug Discovery·Sophie BonnalJuan Valcárcel
Jul 7, 2019·Nature Reviews. Cancer·Christof C SmithJonathan S Serody
Dec 14, 2016·Blood·Patrick Auberger, Alexandre Puissant
Nov 7, 2014·Oncotarget·Aminetou Mint MohamedEric Wattel
May 31, 2019·Investigational New Drugs·Joana JorgeAna Bela Sarmento-Ribeiro
Mar 8, 2019·Wiley Interdisciplinary Reviews. RNA·Vincent BoivinSherif Abou-Elela
Dec 18, 2014·World Journal of Gastroenterology : WJG·Bahityar RahmutullaFumio Nomura
Oct 12, 2020·Cell Death & Disease·Pooja PopliRamakrishna Kommagani
Dec 19, 2020·Leukemia & Lymphoma·Ami B Patel, Michael W Deininger
May 7, 2013·Molecular Cancer Research : MCR·Connie A LarssonAlfonso Quintás-Cardama
Oct 17, 2019·Cold Spring Harbor Perspectives in Medicine·Camila Prieto, Michael G Kharas

Related Concepts

Hematological Disease
Hematopoetic Myelodysplasia
RNA, Messenger, Splicing
Hematological Disease
RNA, Messenger, Splicing
U2AF1 protein, human
SF3A1 protein, human

Related Feeds

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.